Nematodes Affecting Potato and Sustainable Practices for Their Management

Plant-parasitic nematodes are a significant factor limiting potato production and tuber quality in several regions where potato is produced. Overall, parasitic nematodes alone cause an estimated annual crop loss of $ 78 billion worldwide and an average crop yield loss of 10–15%. As a result, sustainable food production and food security are directly impacted by pests and diseases. Degrading land use with monocultures and unsustainable cropping practices have intensified problems associated with plant pathogens. Proper identification of nematode species and isolates is crucial to choose effective and sustainable management strategies for nematode infection. Several nematode species have been reported associated with potato. Among those, the potato cyst nematodes Globodera rostochiensis and G. pallida, the root-knot nematode Meloidogyne spp., the root lesion nematode Pratylenchus spp., the potato rot nematode Ditylenchus destructor and the false root-knot nematode Nacobbus aberrans are major species limiting potato yield and leading to poor tuber quality. Here, we report a literature review on the biology, symptoms, damage and control methods used for these nematode species

Serial clinical and echocardiographic evaluation in children with Marfan syndrome

OBJECTIVE: To describe the clinical cardiac manifestations and temporal evolution of Marfan syndrome in children; to estimate the incidence of annuloaortic ectasia and mitral valve prolapse; and to evaluate tolerability and efficacy of beta-blockers in these patients. METHODS: During one year, 21children with Marfan syndrome underwent serial clinical and echocardiographic examinations. Echocardiograms assessed: the presence of mitral valve prolapse, aortic root diameter, mitral and aortic valves regurgitation, and aortic enlargement during beta-blocker therapy. Eleven patients had two measurements of the aortic root taken one year apart. RESULTS: The children were asymptomatic throughout the study. Mitral prolapse was found in 11 (52%) children. Annuloaortic ectasia occurred in 16 (76%) patients and found to be mild in 42.8%, moderate in 9.5%, and severe in 23.8%. One of these patients underwent aortic valve replacement and repair of the ascending aorta by the Bentall-De Bono technique, with good results. Heart rate decreased by 13.6% (from 85 to 73 bpm; p < 0.009) with the use of beta-blockers; however, aortic root diameter increased by 1.4 mm/year (p<0.02). One child could not be given beta-blockers due to bronchial asthma, and no significant side effects were observed in the remaining children, including one who also had bronchial asthma. CONCLUSION: The children remained asymptomatic throughout the study, the use of beta-blockers led to a significant decrease in heart rate, and no significant adverse effects were observed. Contrary to the literature, incidence of annuloaortic ectasia was high among the study population, greater than that of mitral valve prolapse, even during beta-blocker therapy.OBJETIVO: Descrever a apresentação clínica cardiológica e a evolução temporal, estimar a incidência de ectasia ânulo-aórtica e de prolapso da valva mitral, e avaliar a tolerância e a efetividade dos betabloqueadores em crianças com síndrome de Marfan. MÉTODOS: Foram submetidas a exame clínico e ecocardiográfico seriado, durante um ano, 21 crianças com síndrome de Marfan. No ecocardiograma foram analisados: presença de prolapso mitral, diâmetro da raiz aórtica, refluxos das valvas mitral e aórtica, e o crescimento dos diâmetros aórticos na vigência de betabloqueadores. Em 11 pacientes foi possível obter duas medidas da raiz aórtica no intervalo de um ano. RESULTADOS: Durante o estudo as crianças não apresentaram sintomas. Prolapso mitral foi encontrado em 11 (52%) crianças. Ectasia ânulo-aórtica ocorreu em 16 (76%) pacientes, sendo de grau discreto em 42,8%, moderado em 9,5%, e importante em 23,8%. Um desses pacientes foi submetido com sucesso à cirurgia de Bentall DeBono. Com o uso de betabloqueador a freqüência cardíaca diminuiu 13,6% (de 85 para 73 bpm; p < 0,009), mas houve um crescimento da raiz aórtica de 1,4 mm/ano (p < 0,02). Uma criança não pôde receber betabloqueador em razão de asma brônquica, e não foram observados efeitos colaterais significativos nas outras crianças, incluindo uma com asma brônquica. CONCLUSÃO: Os resultados obtidos sugerem que, no período observado, as crianças permaneceram assintomáticas, o uso de betabloqueadores diminuiu significativamente a freqüência cardíaca e não se acompanhou de efeitos adversos significativos. Ao contrário da literatura, a incidência de ectasia ânulo-aórtica foi elevada e maior do que a de prolapso valvar mitral, tendo crescimento mesmo na vigência de uso eficaz de betabloqueador.Universidade Federal de São Paulo (UNIFESP)UNIFESPSciEL

Canine \u3b2-defensin-1 (CBD1) gene as a possible marker for Leishmania infantum infection in dogs

Canine leishmaniasis caused by Leishmania infantum is a parasitic disease of great veterinary significance. Some dogs infected by L. infantum may mount a strong cellular immune response and clear the infection, while others may respond with exaggerated antibody production against the parasite and develop an overt disease, which may be fatal, if left untreated. The initial factors triggering the polarization of the immune response towards a predominantly T-helper 1 or T-helper 2 cytokines, as well as the markers of resistance and susceptibility to L. infantum infection and disease development in dogs, are not fully understood. Herein, we assessed the association between single nucleotide polymorphisms (SNPs) in the canine \u3b2-defensin-1 (CBD1) gene and the infection by L. infantum in two dog populations from Brazil (Sobral in Cear\ue1 State and S\ue3o Raimundo Nonato in Piau\ued State) and one dog population from Italy

Estimate of body growth curve and feed intake of free-range chickens receiving different levels of digestible lysine

Aim of the study: To adjust nonlinear Gompertz model to describe the body growth and feed intake (FI) of free-range chickens of the CPK (Color Plumé) strain, receiving different levels of digestible lysine (dig-Lys), from 21 to 77 days of age.Area of study: São Cristovão, Sergipe, Brazil.Material and methods: A total of 432 one-day-old unsexed chickens were used in the study. At 21 days of age, the birds were assigned to four treatments (0.85%; 0.97%; 1.09%; 1.21%) of dig-Lys, in a completely randomized design with four replicates, with 27 birds per experimental unit. The Gompertz model was used to estimate bird growth curves related to body weight (BW) and FI at each Lys level.Main results: The tests of comparison between the parameters of the Gompertz model for each Lys level showed that parameter A varied, while parameters B (0.0329) and C (45.819) did not differ significantly. In parameter A, the dig-Lys level of 0.97% provided the highest BW estimate at maturity and maximum BW at the inflection point.Research highlights: Use of non-linear models to predict nutritional requirements, helps farmers to optimize management decisions and, thus, maximize their profit. According to Gompertz model, it was possible to infer that the inclusion of 0.97% dig-Lys in the diet of mixed batches of free-range chickens of the CPK strain meets their nutritional requirements

The new nitric oxide donor cyclohexane nitrate induces vasorelaxation, hypotension, and antihypertensive effects via NO/cGMP/PKG pathway

We investigated the cardiovascular effects induced by the nitric oxide donor Cyclohexane Nitrate (HEX). Vasodilatation, NO release and the effects of acute or sub-chronic treatment with HEX on cardiovascular parameters were evaluated. HEX induced endothelium-independent vasodilatation (Maximum effect- [efficacy, ME] = 100.4±4.1%; potency [pD2] = 5.1±0.1). Relaxation was attenuated by scavenging nitric oxide (ME = 44.9±9.4% vs. 100.4±4.1%) or by inhibiting the soluble guanylyl cyclase (ME = 38.5±9.7% vs. 100.4±4.1%). In addition, pD2 was decreased after non-selective blockade of K+ channels (pD2 = 3.6±0.1 vs. 5.1±0.1) or by inhibiting KATP channels (pD2 = 4.3±0.1 vs. 5.1±0.1). HEX increased NO levels in mesenteric arteries (33.2±2.3 au vs. 10.7±0.2 au, p<0.0001). Intravenous acute administration of HEX (1-20 mg/kg) induced hypotension and bradycardia in normotensive and hypertensive rats. Furthermore, starting at six weeks after the induction of 2K1C hypertension, oral treatment with the HEX (10 mg/Kg/day) for seven days reduced blood pressure in hypertensive animals (134±6 vs 170±4 mmHg, respectively). Our data demonstrate that HEX is a NO donor able to produce vasodilatation via NO/cGMP/PKG pathway and activation of the ATP-sensitive K+ channels. Furthermore, HEX acutely reduces blood pressure and heart rate as well as produces antihypertensive effect in renovascular hypertensive rats